[Ceftolozane/tazobactam (bacterial infections) - Assessment according to §35a (para. 1c) Social Code Book V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004141
German
Original Title:
Ceftolozan/Tazobactam (bakterielle Infektionen, mehrere Anwendungsgebiete) - Bewertung gemäß § 35a Abs. 1c SGB V
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g22-18.html
Year Published:
2022
URL for published report:
https://www.iqwig.de/download/g22-18_ceftolozan-tazobactam_bewertung-35a-absatz-1c-sgb-v_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Healthcare-Associated Pneumonia
- Intraabdominal Infections
- Urinary Tract Infections
- Pyelonephritis
- Tazobactam
- Anti-Bacterial Agents
- Cephalosporins
- Anti-Infective Agents, Urinary
- beta-Lactamase Inhibitors
Keywords
- Ceftolozane
- Tazobactam
- Healthcare-Associated Pneumonia
- Intraabdominal Infections
- Urinary Tract Infections
- Pyelonephritis
- Health Care Costs
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.